From the databaseWhat the row says.
Every entry follows the same shape: what is happening, the mechanism, and the recommendation.
Scope
Supplement × Supplement
Last verified
June 4, 2026
CautionEmerging evidence
What is happening. Both are marketed for fat metabolism and may have additive effects on lipid oxidation and thermogenesis. The combination is not inherently harmful, but high-dose green tea extract (EGCG) carries a known risk of hepatotoxicity, and stacking multiple metabolic botanicals increases the burden on the liver.
Mechanism. Potential additive metabolic effects on thermogenesis and fat oxidation; independent hepatotoxicity risk from concentrated EGCG that could compound with other hepatically processed botanicals.
Recommendation. Avoid stacking high-dose extracts and keep green tea extract within conservative EGCG limits. Anyone with liver concerns or who develops fatigue, dark urine, or jaundice should stop and seek care. Prefer taking with food.
Stack Score
How it moves the number.
Effect on the composite score
If both Fucoxanthin and Green Tea Extract are in the same stack, this pair applies −5 to your Stack Score (per scored caution row).
The full algorithm, the clamping rules, and four worked stacks are at /methodology/stack-score.
SourcesSources, by evidence tier.
Every claim on this page is cited. PMIDs link straight to PubMed.
Reference material
2- 1Oliveira CSS, et al. Green tea extract and hepatotoxicity: a systematic review. World J Hepatol. 2019.Needs sourceNo link
- 2Maeda H, et al. Fucoxanthin and its metabolite fucoxanthinol in cancer prevention and treatment. Arch Biochem Biophys. 2018.Needs sourceNo link